First-in-human pharmacokinetic and pharmacodynamic study of the dual m-TORC 1/2 inhibitor, AZD2014

per Basu, Bristi, Dean, Emma, Puglisi, Martina, Greystoke, Alastair, Ong, Michael, Burke, Wendy, Cavallin, Maria, Bigley, Graham, Womack, Christopher, Harrington, Elizabeth A, Green, Stephen, Oelmann, Elisabeth, de Bono, Johann S, Ranson, Malcolm, Banerji, Udai
Publicat a Clin Cancer Res (2015)

A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies

per Platt, Adam, Morten, John, Ji, Qunsheng, Elvin, Paul, Womack, Chris, Su, Xinying, Donald, Emma, Gray, Neil, Read, Jessica, Bigley, Graham, Blockley, Laura, Cresswell, Carl, Dale, Angela, Davies, Amanda, Zhang, Tianwei, Fan, Shuqiong, Fu, Haihua, Gladwin, Amanda, Harrod, Grace, Stevens, James, Williams, Victoria, Ye, Qingqing, Zheng, Li, de Boer, Richard, Herbst, Roy S, Lee, Jin-Soo, Vasselli, James
Publicat a BMC Cancer (2015)